SCHEMBL21783250

SCHEMBL21783250

NS(=O)O[C@H]1CC(COCc2ccccc2)[C@@H](OCc2ccccc2)C(OCc2ccccc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 2/20 0.47
ACHE P22303 2/20 0.47
PDE4D Q08499 1/20 0.37
SSTR1 P30872 2/20 0.35
SSTR2 P30874 2/20 0.35
SSTR4 P31391 2/20 0.35
SSTR3 P32745 2/20 0.35
SSTR5 P35346 2/20 0.35
PDPK1 O15530 1/20 0.35
MTOR P42345 1/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34
LMNA P02545 1/20 0.34
GJB2 P29033 2/20 0.34
AGTR2 P50052 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21783181 0.80 BCHE (0.46) BCHEACHEPDE4DSSTR1SSTR2
SCHEMBL21783194 0.78 BCHE (0.52) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL21783252 0.78 BCHE (0.44) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL21783251 0.77 BCHE (0.44) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL21783307 0.75 BCHE (0.46) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL22765220 0.73 BCHE (0.49) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL22747926 0.73 BCHE (0.49) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL21783273 0.72 BCHE (0.55) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL21783190 0.72 BCHE (0.55) BCHEACHEPDE4DPDPK1MTOR
SCHEMBL12152955 0.72 BCHE (0.48) BCHEACHEPDE4DSSTR1SSTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020046132-A1 PHARMACOLOGICAL CHAPERONES FOR ENZYME TREATMENT THERAPY LEIDEN UNIVERSITY (NL) 2020-03-05 WO disclosed